Found: 98
Select item for more details and to access through your institution.
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Published in:
- Nutrients, 2024, v. 16, n. 13, p. 1, doi. 10.3390/nu16132027
- By:
- Publication type:
- Article
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.
- Published in:
- Diabetologia, 2017, v. 60, n. 10, p. 1873, doi. 10.1007/s00125-017-4340-1
- By:
- Publication type:
- Article
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?
- Published in:
- Diabetologia, 2016, v. 59, n. 6, p. 1145, doi. 10.1007/s00125-016-3930-7
- By:
- Publication type:
- Article
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas.
- Published in:
- Acta Diabetologica, 2011, v. 48, n. 4, p. 337, doi. 10.1007/s00592-011-0293-x
- By:
- Publication type:
- Article
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010028
- By:
- Publication type:
- Article
The sclerotic component of metabolic syndrome: Fibroblast activities may be the central common denominator driving organ function loss and death.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2554, doi. 10.1111/dom.15615
- By:
- Publication type:
- Article
Inflammatory Bowel Disease Nurse—Practical Messages.
- Published in:
- Nursing Reports, 2021, v. 11, n. 2, p. 229, doi. 10.3390/nursrep11020023
- By:
- Publication type:
- Article
Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease.
- Published in:
- Nutrients, 2023, v. 15, n. 24, p. 5053, doi. 10.3390/nu15245053
- By:
- Publication type:
- Article
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Nutrients, 2023, v. 15, n. 14, p. 3257, doi. 10.3390/nu15143257
- By:
- Publication type:
- Article
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD.
- Published in:
- Nutrients, 2023, v. 15, n. 13, p. 3018, doi. 10.3390/nu15133018
- By:
- Publication type:
- Article
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs.
- Published in:
- Nutrients, 2023, v. 15, n. 3, p. 792, doi. 10.3390/nu15030792
- By:
- Publication type:
- Article
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 23, p. 5053, doi. 10.3390/nu14235053
- By:
- Publication type:
- Article
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes, 2001, v. 50, n. 8, p. 1844, doi. 10.2337/diabetes.50.8.1844
- By:
- Publication type:
- Article
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 267, doi. 10.3390/antibiotics13030267
- By:
- Publication type:
- Article
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39998-2
- By:
- Publication type:
- Article
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-35736-2
- By:
- Publication type:
- Article
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 12757, doi. 10.1038/ncomms12757
- By:
- Publication type:
- Article
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
- Published in:
- Nature Communications, 2015, v. 6, n. 3, p. 6422, doi. 10.1038/ncomms7422
- By:
- Publication type:
- Article
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1172, doi. 10.3390/ijms24021172
- By:
- Publication type:
- Article
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8838, doi. 10.3390/ijms21228838
- By:
- Publication type:
- Article
Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 24, p. 6333, doi. 10.3390/ijms20246333
- By:
- Publication type:
- Article
Pathophysiology of Non Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 12, p. 2082, doi. 10.3390/ijms17122082
- By:
- Publication type:
- Article
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 5, p. 717, doi. 10.3390/ijms17050717
- By:
- Publication type:
- Article
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 479, doi. 10.3390/ijms17040479
- By:
- Publication type:
- Article
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2418, doi. 10.1111/liv.15377
- By:
- Publication type:
- Article
A cholestatic pattern predicts major liver‐related outcomes in patients with non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1037, doi. 10.1111/liv.15232
- By:
- Publication type:
- Article
Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1999, doi. 10.1111/liv.15013
- By:
- Publication type:
- Article
Natural history of NASH.
- Published in:
- Liver International, 2021, v. 41, p. 78, doi. 10.1111/liv.14910
- By:
- Publication type:
- Article
Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1227, doi. 10.1111/liv.14825
- By:
- Publication type:
- Article
Mechanisms for increased risk of diabetes in chronic liver diseases.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2489, doi. 10.1111/liv.14556
- By:
- Publication type:
- Article
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with non‐alcoholic fatty liver: An external validation study.
- Published in:
- Liver International, 2018, v. 38, n. 4, p. 715, doi. 10.1111/liv.13612
- By:
- Publication type:
- Article
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1389, doi. 10.1111/liv.13397
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
- Published in:
- Liver International, 2016, v. 36, n. 11, p. 1563, doi. 10.1111/liv.13185
- By:
- Publication type:
- Article
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
- Published in:
- Liver International, 2016, v. 36, n. 10, p. 1549, doi. 10.1111/liv.13150
- By:
- Publication type:
- Article
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0299487
- By:
- Publication type:
- Article
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5457, doi. 10.3390/curroncol29080431
- By:
- Publication type:
- Article
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
- Published in:
- Minerva Gastroenterology, 2022, v. 68, n. 4, p. 378, doi. 10.23736/S2724-5985.21.03006-0
- By:
- Publication type:
- Article
Cognitive-Behavioral Treatment of Nonalcoholic Fatty Liver Disease: A Propensity Score-Adjusted Observational Study.
- Published in:
- Obesity (19307381), 2011, v. 19, n. 4, p. 763, doi. 10.1038/oby.2010.254
- By:
- Publication type:
- Article
Increased prevalence of high‐risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta‐analysis.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 9, p. 1, doi. 10.1111/eci.14188
- By:
- Publication type:
- Article
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1212, doi. 10.1111/apt.17941
- By:
- Publication type:
- Article
Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 249, doi. 10.1111/apt.17768
- By:
- Publication type:
- Article
Liver‐related and extrahepatic events in patients with non‐alcoholic fatty liver disease: a retrospective competing risks analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 604, doi. 10.1111/apt.16763
- By:
- Publication type:
- Article
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.716533
- By:
- Publication type:
- Article
Response to Yeh.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Incidence of Type 2 Diabetes Mellitus and Glucose Abnormalities in Patients With Chronic Hepatitis C Infection by Response to Treatment: Results of a Cohort Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 10, p. 2481, doi. 10.1111/j.1572-0241.2008.02002.x
- By:
- Publication type:
- Article
Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2007, v. 102, n. 6, p. 1251, doi. 10.1111/j.1572-0241.2007.01192.x
- By:
- Publication type:
- Article